Visual Versus Conventional Intubation Using the SaCoVLM Video Laryngeal Mask (SACOV-VS-DL)

January 16, 2026 updated by: Emel Gunduz, Akdeniz University

Visual Versus Conventional Intubation: Comparison of SaCoVLM™ Video Laryngeal Mask and Direct Laryngoscopy : A Prospective Observational Study

This is a prospective, observational study designed to evaluate airway management techniques used during elective surgery under general anesthesia. The study focuses on perioperative hemodynamic parameters and airway-related procedural characteristics.

Study Overview

Status

Completed

Conditions

Detailed Description

Study Design This is a single-center, prospective, observational study conducted at Akdeniz University Hospital after approval by the Institutional Ethics Committee (Approval No: 70904504/139). Written informed consent was obtained from all participants prior to enrollment.

Participants Adult patients scheduled for elective surgery under general anesthesia between March and June 2024 were screened for inclusion.

Exclusion Criteria Patients were excluded if they were under 18 years of age, pregnant, had known hypersensitivity to anesthetic agents, gastroesophageal reflux disease, or active upper respiratory tract infection.

Group Allocation and Airway Management

Due to the observational design of the study, randomization was not performed. Patients were allocated to groups according to the airway management technique selected by the attending anesthesiologist:

SaCoVLM™ video laryngeal mask group (VLM)

Direct laryngoscopy group (DL)

All airway procedures were performed by anesthesiologists with at least three years of clinical experience and a minimum of 50 prior successful supraglottic airway device and endotracheal intubations.

Devices The SaCoVLM™ is a video-integrated supraglottic airway device with separate channels for ventilation, visualization, and gastric access. Mask size selection was based on patient body weight.

In the DL group, Macintosh laryngoscope blades (sizes 3 or 4) were used according to clinician preference.

Preoperative Assessment Pre-induction airway evaluation included Mallampati score, upper lip bite test, neck circumference, thyromental distance, sternomental distance, and interincisor gap. The STOP-Bang questionnaire was completed preoperatively.

Anesthesia Protocol All patients fasted for at least 8 hours for solids and 6 hours for liquids. Standard monitoring included ECG, non-invasive blood pressure, pulse oximetry, bispectral index (BIS), and capnography.

Preoxygenation was performed with 80% oxygen for 2 minutes. Anesthesia induction was achieved using thiopental, fentanyl, lidocaine, and rocuronium. Airway intervention was initiated once BIS values decreased below 50.

Airway Procedure and Measurements In the VLM group, the time from device insertion to visualization of the glottis was recorded. After confirmation of ventilation using capnography, a lubricated endotracheal tube was advanced through the device, and the time from tube insertion to passage through the vocal cords was recorded.

In the DL group, the time from laryngoscope insertion to passage of the endotracheal tube through the vocal cords was recorded.

Glottic visualization was assessed using the SaCoVLM™ visualization scale in the VLM group and the Cormack-Lehane classification in the DL group.

Cuff pressures were maintained below 60 cmH₂O for the laryngeal mask and below 25 cmH₂O for endotracheal tubes.

Hemodynamic Monitoring Hemodynamic parameters including systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate, and oxygen saturation were recorded at predefined time points: preoperative baseline, post-induction, post-laryngeal mask insertion, and post-endotracheal tube placement.

Maintenance and Emergence Anesthesia was maintained with sevoflurane titrated to a BIS value of 40-60 and a remifentanil infusion. At the end of surgery, anesthetic agents were discontinued and extubation was performed once patients regained consciousness and responded to verbal commands.

Outcome Measures Primary outcomes included hemodynamic responses to airway management, first-attempt success, airway procedure time, and airway-related complications.

Secondary outcomes included the need for adjunct airway maneuvers, glottic visualization grading, and postoperative airway-related adverse events.

Sample Size Calculation Sample size estimation was based on prior literature using an effect size of 1.68, an alpha level of 0.05, and a statistical power of 95%, resulting in a minimum required sample size of 22 patients per group.

Statistical Analysis Statistical analysis was planned using appropriate parametric methods following assessment of data distribution. A p-value of <0.05 was considered statistically significant.

Study Type

Observational

Enrollment (Actual)

204

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Please Select:
      • Antalya, Please Select:, Turkey (Türkiye), 07050
        • Akdeniz University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This study included adult patients (≥18 years old) scheduled for elective surgery under general anesthesia at Akdeniz University Hospital between March and June 2024. Both male and female patients were eligible. Patients with known hypersensitivity to anesthetic agents, pregnant patients, those with gastroesophageal reflux disease, or active upper respiratory tract infections were excluded. A total of 204 patients were enrolled.

Description

Inclusion Criteria:

Age ≥ 18 years

Scheduled for elective surgery under general anesthesia

Requires tracheal intubation as part of the planned anesthetic technique

American Society of Anesthesiologists (ASA) physical status I-III

Able to provide written informed consent

Exclusion Criteria:

Age < 18 years

Pregnancy

Known or suspected hypersensitivity to anesthetic agents used in the protocol

History of gastroesophageal reflux disease or increased risk of aspiration

Active upper respiratory tract infection

Predicted difficult airway (Mallampati class IV, mouth opening < 3 cm, limited neck mobility)

Severe cardiopulmonary instability

Emergency surgery

Upper airway pathology (airway trauma, tumor, edema, infection)

Coagulopathy or bleeding tendency

Inability to cooperate or provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Group 1: SaCoVLM™ Video Laryngeal Mask Group 2: Direct Laryngoscopy

Group 1: SaCoVLM™ Video Laryngeal Mask (VLM), "Intubation performed using SaCoVLM™ video laryngeal mask under general anesthesia."

Group 2: Direct Laryngoscopy (DL),: "Intubation performed using direct laryngoscopy under general anesthesia."

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mean Arterial Pressure During Intubation
Time Frame: Baseline (pre-induction) and 1 minute after endotracheal tube placement
Mean arterial pressure (MAP) measured non-invasively at baseline (before induction of anesthesia) and at 1 minute after successful endotracheal tube placement.
Baseline (pre-induction) and 1 minute after endotracheal tube placement

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First-Attempt Intubation Success
Time Frame: During airway instrumentation (peri-procedural) Unit of Measure Percentage (%)
Successful placement of the endotracheal tube on the first attempt, confirmed by continuous capnography.
During airway instrumentation (peri-procedural) Unit of Measure Percentage (%)
Heart Rate Response to Intubation
Time Frame: Baseline (pre-induction) and 1 minute after endotracheal tube placement Unit of Measure beats per minute
Heart rate measured at baseline (before induction of anesthesia) and at 1 minute after endotracheal tube placement.
Baseline (pre-induction) and 1 minute after endotracheal tube placement Unit of Measure beats per minute
Oxygen Saturation During Airway Management
Time Frame: Baseline and during airway instrumentation Unit of Measure Percentage (%)
Peripheral oxygen saturation (SpO₂) measured at baseline and during airway instrumentation.
Baseline and during airway instrumentation Unit of Measure Percentage (%)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 29, 2025

Primary Completion (Actual)

November 10, 2025

Study Completion (Actual)

December 23, 2025

Study Registration Dates

First Submitted

November 26, 2025

First Submitted That Met QC Criteria

January 16, 2026

First Posted (Actual)

January 26, 2026

Study Record Updates

Last Update Posted (Actual)

January 26, 2026

Last Update Submitted That Met QC Criteria

January 16, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • AKDENIZ_SACOVLM_INTUBATION_01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) from this study will not be shared with other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Management

Subscribe